CubaHeadlines

Phase 3 Clinical Trial

Explore advancements and outcomes in pivotal Phase 3 clinical trials, focusing on life-changing treatments and drug approvals, such as Hovilpri for resistant herpes.

FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults
FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults

Published on 10/10/2026